colorectal (colon) cancer; epidermal growth factor receptor (EGFR); RAS; liquid biopsy; rechallenge; cetuximab; RAS; ...

Explore the challenges and advancements in anti-EGFR antibody treatment for metastatic colorectal cancer. Discover how ...

Kelun-Biotech has become the second drugmaker to bring a TROP2-directed antibody-drug conjugate to regulatory approval, ...

2024 年 12 月 6 日 - 8 日，欧洲肿瘤内科学会亚洲年会（ESMO Asia）将在新加坡盛大召开。本届会议将汇聚全球专家学者，集中展示和讨论肿瘤学领域的最新科学和临床进展，为肿瘤领域带来一场学术盛宴。此次会议中，「Dato-DXd ...

A technology has been developed that can analyze tumor mutations in lung cancer patients to confirm drug resistance to ...

In a randomized controlled trial of people with type 2 diabetes, albuminuria, and estimated glomerular filtration rate (eGFR) between 25 and 75 mL/min/1.73 m2, subcutaneous semaglutide reduced the ...

SGLT2 inhibitors are a new family of agents ... 2.4/CANA100 mg: 3.1/PL: 0 eGFR (mL/min/1.73 m 2):/CANA300 mg: −3.9/CANA100 mg: −3.6/PL: −1.4 eGFR (percentage changes %):/CANA300 mg: − ...

Bevacizumab biosimilars have the potential to expand access and reduce costs without compromising patient outcomes in ...

The new guideline also recommends faster tapering to a lower dose of glucocorticoids and a longer duration of ...

After hours: November 27 at 6:50 PM EST Loading Chart for GFR ...

在国家自然科学基金项目（批准号：82072784、82072785、82273304、82303437）等资助下，复旦大学附属华山医院毛颖教授、花玮教授和迟喻丹研究员团队在免疫逃逸参与肺癌脑转移靶向治疗耐药研究方面取得进展。研究成果以“通过CTLA4 ...

Researchers evaluate the effects of glucagon-like peptide-1 receptor agonists on kidney and cardiovascular outcomes.